2020. PROSPECTS OF COMBINING INTERLEUKIN-2 WITH IMMUNE CHECKPOINT INHIBITORS FOR CANCER THERAPY. Voprosy onkologii. 66, 1 (Jan. 2020), 23–28. DOI:https://doi.org/10.37469/0507-3758-2020-66-1-23-28.